Serum sCD25 Protein as a Predictor of Lack of Long-Term Benefits from Immunotherapy in Non-Small Cell Lung Cancer: A Pilot Study

SIMPLE SUMMARY: The prognosis of advanced lung cancer is poor. Even though it can improve with immunotherapy, most patients do not respond to treatment. Identifying patients who would not benefit from therapy is an unmet goal. We hypothesized that one of the molecules present in human serum (namely,...

Descripción completa

Detalles Bibliográficos
Autores principales: Siemiątkowska, Anna, Bryl, Maciej, Kosicka-Noworzyń, Katarzyna, Tvrdoň, Jakub, Gołda-Gocka, Iwona, Barinow-Wojewódzki, Aleksander, Główka, Franciszek K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345204/
https://www.ncbi.nlm.nih.gov/pubmed/34359602
http://dx.doi.org/10.3390/cancers13153702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345204/
https://www.ncbi.nlm.nih.gov/pubmed/34359602
http://dx.doi.org/10.3390/cancers13153702

Ejemplares similares